Who owns DRUGS MADE IN AMER ACQUTN CO?
- Ticker: DMAA
- CUSIP Number: g2847j104
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acqutn with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In Amer Acqutn stock
Who bought or sold DRUGS MADE IN AMER ACQUTN CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Karpus Investment Management | 2.5M | $26M | -7% | Sep 2025 |
|
| Vivaldi Asset Management | 2.2M | $23M | 0% | Sep 2025 |
|
| Polar Securities | 1.9M | $20M | 0% | Sep 2025 |
|
| Glazer Capital | 1.8M | $19M | 0% | Sep 2025 |
|
| Westchester Capital Management | 1.7M | $17M | 0% | Sep 2025 |
|
| Hudson Bay Capital Management | 1.6M | $16M | -14% | Sep 2025 |
|
| Wolverine Asset Management | 1.2M | $13M | 22% | Sep 2025 |
|
| Mizuho Securities Usa | 1.1M | $11M | 20% | Sep 2025 |
|
| Aristeia Capital | 882k | $9.1M | 0% | Sep 2025 |
|
| D. E. Shaw & Co | 690k | $7.1M | 0% | Sep 2025 |
|
| Heights Capital Management | 650k | $6.7M | 0% | Sep 2025 |
|
| Radcliffe Capital Management | 528k | $5.4M | 317% | Sep 2025 |
|
| LMR Partners | 500k | $5.1M | 0% | Sep 2025 |
|
| Boothbay Fund Management | 500k | $5.1M | -12% | Sep 2025 |
|
| Atw Spac Management | 500k | $5.1M | -12% | Sep 2025 |
|
| J. Goldman & Co | 500k | $5.1M | 100% | Sep 2025 |
|
| Toronto-Dominion Bank | 450k | $4.6M | -10% | Sep 2025 |
|
| Whitebox Advisors | 400k | $4.1M | 0% | Sep 2025 |
|
| CNH Partners | 371k | $3.8M | -1% | Sep 2025 |
|
| Rivernorth Capital Management | 318k | $3.3M | 100% | Sep 2025 |
|
| Context Capital Management | 250k | $2.6M | 100% | Sep 2025 |
|
| Shaolin Capital Management | 150k | $1.5M | 50% | Sep 2025 |
|
| Brooklyn Capital Management | 130k | $1.3M | 79% | Sep 2025 |
|
| Goldman Sachs Group | 120k | $1.2M | 0% | Sep 2025 |
|
| DLD Asset Management | 114k | $1.2M | -40% | Sep 2025 |
|
| Clear Street | 113k | $1.1M | 100% | Jun 2025 |
|
| Jpmorgan Chase & Co | 100k | $1.0M | 100% | Sep 2025 |
|
| Warberg Asset Management | 92k | $945k | 0% | Sep 2025 |
|
| Periscope Capital | 50k | $514k | 100% | Sep 2025 |
|
| Geode Capital Management | 46k | $469k | 0% | Sep 2025 |
|
| Oakmont Partners | 36k | $374k | 100% | Sep 2025 |
|
| Hrt Financial | 28k | $282k | 100% | Sep 2025 |
|
| UBS Group | 20k | $207k | 2012000% | Sep 2025 |
|
| Quarry | 16k | $162k | 100% | Sep 2025 |
|
| Sandia Investment Management | 16k | $162k | 100% | Sep 2025 |
|
| Governors Lane | 11k | $115k | 100% | Sep 2025 |
|
| Morgan Stanley | 109.00 | $1.1k | 100% | Jun 2025 |
|
Who sold out of Drugs Made In Amer Acqutn?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mangrove Partners | Jun 2025 | 350k | $3.6M |
| Schonfeld Strategic Advisors | Jun 2025 | 149k | $1.5M |
| Verition Fund Management | Jun 2025 | 100k | $1.0M |
| Logan Stone Capital | Jun 2025 | 61k | $622k |
| Virtu Financial | Jun 2025 | 47k | $476k |